

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.30498575 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.10948904 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.02738353 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.02738353 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.02738353 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.02738353 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.02738353 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.02738353 |
| 9 | response to peptidoglycan (GO:0032494) | 4.94308713 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.83434808 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.83434808 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.63311414 |
| 13 | granulocyte activation (GO:0036230) | 4.40688927 |
| 14 | detection of other organism (GO:0098543) | 4.30433080 |
| 15 | detection of bacterium (GO:0016045) | 4.27517935 |
| 16 | neutrophil activation (GO:0042119) | 4.27317882 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.25085866 |
| 18 | * respiratory burst (GO:0045730) | 4.22227241 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.12280812 |
| 20 | leukocyte aggregation (GO:0070486) | 4.03119089 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.02061675 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97892393 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94497978 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.87659456 |
| 25 | positive regulation of antigen processing and presentation (GO:0002579) | 3.82783059 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.77231778 |
| 27 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.70322391 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70252996 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70252996 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.69651927 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68744573 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 3.68157873 |
| 33 | cellular response to zinc ion (GO:0071294) | 3.67852217 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.67794031 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66512826 |
| 36 | B cell mediated immunity (GO:0019724) | 3.61768258 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.56468807 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.55045162 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.51116146 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.48422096 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46845696 |
| 42 | response to host immune response (GO:0052572) | 3.46845696 |
| 43 | defense response to protozoan (GO:0042832) | 3.45553810 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.43503430 |
| 45 | type I interferon signaling pathway (GO:0060337) | 3.42923044 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.42923044 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 3.42521254 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.41630378 |
| 49 | response to type I interferon (GO:0034340) | 3.40220751 |
| 50 | cellular response to interferon-beta (GO:0035458) | 3.39921064 |
| 51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36976836 |
| 52 | regulation of leukocyte degranulation (GO:0043300) | 3.36094459 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.35621360 |
| 54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.35209435 |
| 55 | positive regulation of mast cell degranulation (GO:0043306) | 3.35209435 |
| 56 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.34944213 |
| 57 | natural killer cell mediated immunity (GO:0002228) | 3.34944213 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.34779788 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.32743841 |
| 60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31704638 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31703920 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.31296062 |
| 63 | regulation of chemokine biosynthetic process (GO:0045073) | 3.29616255 |
| 64 | myeloid dendritic cell activation (GO:0001773) | 3.28930620 |
| 65 | cellular extravasation (GO:0045123) | 3.24451544 |
| 66 | leukocyte mediated cytotoxicity (GO:0001909) | 3.23980274 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.23595325 |
| 68 | T cell migration (GO:0072678) | 3.22074923 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21283876 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 3.21101729 |
| 71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18655853 |
| 72 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.18344460 |
| 73 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.18201643 |
| 74 | response to protozoan (GO:0001562) | 3.14892713 |
| 75 | detection of biotic stimulus (GO:0009595) | 3.13532208 |
| 76 | positive regulation of interferon-beta production (GO:0032728) | 3.12875703 |
| 77 | * superoxide anion generation (GO:0042554) | 3.12832077 |
| 78 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.12741000 |
| 79 | germinal center formation (GO:0002467) | 3.10563031 |
| 80 | response to interferon-beta (GO:0035456) | 3.09184429 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08821485 |
| 82 | response to host (GO:0075136) | 3.08821485 |
| 83 | response to host defenses (GO:0052200) | 3.08821485 |
| 84 | regulation of mast cell activation (GO:0033003) | 3.07126861 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04533787 |
| 86 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.03454682 |
| 87 | regulation of mononuclear cell migration (GO:0071675) | 3.02859231 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 3.02742172 |
| 89 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02728228 |
| 90 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.02574964 |
| 91 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.02357176 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01713818 |
| 93 | macrophage activation (GO:0042116) | 3.00573678 |
| 94 | myeloid leukocyte activation (GO:0002274) | 3.00003101 |
| 95 | eosinophil chemotaxis (GO:0048245) | 2.98465223 |
| 96 | lymphocyte chemotaxis (GO:0048247) | 2.98219935 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.97734545 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97259355 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.97165606 |
| 100 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.95811400 |
| 101 | regulation of B cell differentiation (GO:0045577) | 2.94185633 |
| 102 | leukocyte cell-cell adhesion (GO:0007159) | 2.92667599 |
| 103 | positive regulation of interleukin-12 production (GO:0032735) | 2.92385394 |
| 104 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91014541 |
| 105 | mast cell activation (GO:0045576) | 2.90801180 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.90545855 |
| 107 | detection of molecule of bacterial origin (GO:0032490) | 2.90329615 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 2.90178022 |
| 109 | microglial cell activation (GO:0001774) | 2.88089878 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87829117 |
| 111 | mature B cell differentiation involved in immune response (GO:0002313) | 2.87691224 |
| 112 | monocyte chemotaxis (GO:0002548) | 2.87621941 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.86984119 |
| 114 | * hydrogen peroxide biosynthetic process (GO:0050665) | 2.86518739 |
| 115 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85210540 |
| 116 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.84743199 |
| 117 | lymphocyte mediated immunity (GO:0002449) | 2.84591321 |
| 118 | neutrophil chemotaxis (GO:0030593) | 2.84309789 |
| 119 | cellular response to exogenous dsRNA (GO:0071360) | 2.84183555 |
| 120 | negative regulation of interleukin-17 production (GO:0032700) | 2.83729597 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83514607 |
| 122 | eosinophil migration (GO:0072677) | 2.83335463 |
| 123 | dendritic cell differentiation (GO:0097028) | 2.82490534 |
| 124 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.82020786 |
| 125 | neutrophil migration (GO:1990266) | 2.80578646 |
| 126 | T-helper 1 type immune response (GO:0042088) | 2.78011715 |
| 127 | negative regulation of innate immune response (GO:0045824) | 2.77942415 |
| 128 | amino sugar catabolic process (GO:0046348) | 2.76742872 |
| 129 | regulation of superoxide anion generation (GO:0032928) | 2.74905950 |
| 130 | negative thymic T cell selection (GO:0045060) | 2.73711585 |
| 131 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72533960 |
| 132 | regulation of regulated secretory pathway (GO:1903305) | 2.70869229 |
| 133 | T cell selection (GO:0045058) | 2.67691373 |
| 134 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67666300 |
| 135 | negative regulation of interleukin-6 production (GO:0032715) | 2.67663601 |
| 136 | leukocyte degranulation (GO:0043299) | 2.67353040 |
| 137 | neutrophil mediated immunity (GO:0002446) | 2.66214611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.61647220 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.55982426 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.33911225 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.30641095 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.05342467 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.78351207 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64045461 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48578227 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45758661 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.45247325 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.15700340 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.08846017 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.07837356 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01939396 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83197422 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.79224167 |
| 17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.78824070 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66216509 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.54122102 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.41371262 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20948471 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.19001446 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12376072 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09160064 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.00275123 |
| 26 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92287033 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92208218 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86383963 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82135765 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81039152 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80476979 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.78256087 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.77762710 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74972685 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73983923 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73947536 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73470384 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70309128 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67296761 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64619157 |
| 41 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.63894814 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60892708 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60519203 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60183647 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.58925373 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55291612 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45161467 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44478540 |
| 49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42802731 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42090880 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41643250 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40602977 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38559980 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34314853 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33521094 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32534944 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30961995 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30853225 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30542095 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29299520 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27129565 |
| 62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27063365 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24939414 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23274206 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.22779808 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20108607 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18534362 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18214686 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18092811 |
| 70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17662466 |
| 71 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.17412769 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16235599 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14503743 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12732817 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11837495 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11615343 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08059883 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08025412 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07823157 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.06092803 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05845044 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05784968 |
| 83 | * MYC_22102868_ChIP-Seq_BL_Human | 1.03902296 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02556911 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00989974 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00417094 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97272743 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96966711 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96652218 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95449880 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94922697 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93310854 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92625682 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92298691 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92093555 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91550297 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91393572 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91231709 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89732783 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86828270 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85830703 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85210762 |
| 103 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84069354 |
| 104 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82121386 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81606474 |
| 106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.77995214 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76296635 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75567120 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72895180 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.71354339 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.66363442 |
| 112 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66202100 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.64727247 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.63755566 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.63257120 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.63085936 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.61965022 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61139909 |
| 119 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.59674429 |
| 120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.59477777 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.59042064 |
| 122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.59042064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.91968394 |
| 2 | MP0003436_decreased_susceptibility_to | 4.05766258 |
| 3 | MP0009785_altered_susceptibility_to | 3.89128675 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.62661934 |
| 5 | MP0006082_CNS_inflammation | 3.34987797 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.27612234 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.21070801 |
| 8 | * MP0005025_abnormal_response_to | 3.08562603 |
| 9 | MP0003303_peritoneal_inflammation | 3.03065727 |
| 10 | MP0000685_abnormal_immune_system | 2.99948086 |
| 11 | MP0005671_abnormal_response_to | 2.95783906 |
| 12 | MP0003724_increased_susceptibility_to | 2.89892075 |
| 13 | MP0001790_abnormal_immune_system | 2.86605737 |
| 14 | MP0005387_immune_system_phenotype | 2.86605737 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.78701601 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.71511922 |
| 17 | MP0001800_abnormal_humoral_immune | 2.62807344 |
| 18 | MP0002723_abnormal_immune_serum | 2.60017799 |
| 19 | MP0004510_myositis | 2.58393265 |
| 20 | * MP0001819_abnormal_immune_cell | 2.41360819 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.39588300 |
| 22 | MP0001853_heart_inflammation | 2.18348701 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.17663815 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.08852585 |
| 25 | * MP0002405_respiratory_system_inflammati | 2.02289787 |
| 26 | * MP0001845_abnormal_inflammatory_respons | 1.96706100 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.84923947 |
| 28 | MP0004947_skin_inflammation | 1.82865467 |
| 29 | MP0002006_tumorigenesis | 1.81934684 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.81790409 |
| 31 | MP0009764_decreased_sensitivity_to | 1.81123622 |
| 32 | MP0000716_abnormal_immune_system | 1.78699147 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.77432784 |
| 34 | MP0003448_altered_tumor_morphology | 1.72961273 |
| 35 | MP0005310_abnormal_salivary_gland | 1.72236504 |
| 36 | MP0002398_abnormal_bone_marrow | 1.70508915 |
| 37 | MP0008469_abnormal_protein_level | 1.68030669 |
| 38 | MP0000343_altered_response_to | 1.67583494 |
| 39 | MP0000858_altered_metastatic_potential | 1.59489607 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.59431193 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.52472508 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.49218480 |
| 43 | MP0003075_altered_response_to | 1.48339851 |
| 44 | MP0002429_abnormal_blood_cell | 1.46494898 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.44948505 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.44667325 |
| 47 | MP0002722_abnormal_immune_system | 1.36916530 |
| 48 | MP0003186_abnormal_redox_activity | 1.32286105 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.31466096 |
| 50 | MP0005166_decreased_susceptibility_to | 1.24629360 |
| 51 | MP0009278_abnormal_bone_marrow | 1.22251082 |
| 52 | MP0002933_joint_inflammation | 1.21557966 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.20346873 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.20346873 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.18128475 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.16273836 |
| 57 | MP0001873_stomach_inflammation | 1.08362126 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.05965719 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.05737995 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.04617696 |
| 61 | MP0001851_eye_inflammation | 1.03425946 |
| 62 | MP0009840_abnormal_foam_cell | 1.02434604 |
| 63 | MP0003828_pulmonary_edema | 1.01005385 |
| 64 | MP0005390_skeleton_phenotype | 0.99993841 |
| 65 | MP0005174_abnormal_tail_pigmentation | 0.93514318 |
| 66 | MP0002254_reproductive_system_inflammat | 0.92969397 |
| 67 | MP0000490_abnormal_crypts_of | 0.92388458 |
| 68 | MP0009763_increased_sensitivity_to | 0.90006678 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.89698931 |
| 70 | MP0010307_abnormal_tumor_latency | 0.88245129 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 0.87856979 |
| 72 | MP0005164_abnormal_response_to | 0.87823557 |
| 73 | MP0002136_abnormal_kidney_physiology | 0.86883730 |
| 74 | MP0000604_amyloidosis | 0.85436320 |
| 75 | MP0008004_abnormal_stomach_pH | 0.84781522 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.80869603 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 0.79687684 |
| 78 | MP0003866_abnormal_defecation | 0.79169927 |
| 79 | MP0003795_abnormal_bone_structure | 0.78051162 |
| 80 | MP0000249_abnormal_blood_vessel | 0.76511522 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.75902371 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.75723941 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.74118074 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.73604198 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.68890301 |
| 86 | MP0008260_abnormal_autophagy | 0.68727843 |
| 87 | MP0000371_diluted_coat_color | 0.67959809 |
| 88 | MP0001663_abnormal_digestive_system | 0.67683882 |
| 89 | MP0003690_abnormal_glial_cell | 0.66220543 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.65409853 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.65159117 |
| 92 | MP0001958_emphysema | 0.63564305 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.63223671 |
| 94 | MP0004381_abnormal_hair_follicle | 0.62827110 |
| 95 | MP0004858_abnormal_nervous_system | 0.62344019 |
| 96 | MP0008874_decreased_physiological_sensi | 0.62330277 |
| 97 | MP0003329_amyloid_beta_deposits | 0.61108336 |
| 98 | MP0005451_abnormal_body_composition | 0.60757040 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.59979126 |
| 100 | MP0003195_calcinosis | 0.58499211 |
| 101 | MP0004883_abnormal_blood_vessel | 0.58290626 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.58195599 |
| 103 | MP0002019_abnormal_tumor_incidence | 0.57994631 |
| 104 | MP0005165_increased_susceptibility_to | 0.56451459 |
| 105 | MP0002132_abnormal_respiratory_system | 0.56283759 |
| 106 | MP0000609_abnormal_liver_physiology | 0.55673374 |
| 107 | MP0003091_abnormal_cell_migration | 0.54440197 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.54000683 |
| 109 | MP0005023_abnormal_wound_healing | 0.53978227 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53369766 |
| 111 | MP0001849_ear_inflammation | 0.53305118 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.52785127 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.52549091 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.52150457 |
| 115 | MP0008873_increased_physiological_sensi | 0.48431473 |
| 116 | MP0000569_abnormal_digit_pigmentation | 0.47368447 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.46145940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 7.12748421 |
| 2 | * Eczematoid dermatitis (HP:0000976) | 6.28818723 |
| 3 | * Recurrent bacterial skin infections (HP:0005406) | 6.00607456 |
| 4 | * Recurrent gram-negative bacterial infections (HP:0005420) | 5.25055380 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83158396 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.76740516 |
| 7 | * Abnormality of macrophages (HP:0004311) | 4.70863380 |
| 8 | Myositis (HP:0100614) | 4.47805467 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.46202047 |
| 10 | Stomatitis (HP:0010280) | 4.34561101 |
| 11 | * Mediastinal lymphadenopathy (HP:0100721) | 4.34211468 |
| 12 | * Recurrent skin infections (HP:0001581) | 4.04924069 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.98288735 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.96565770 |
| 15 | Orchitis (HP:0100796) | 3.96130273 |
| 16 | * Recurrent fungal infections (HP:0002841) | 3.81715988 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.78679750 |
| 18 | Optic neuritis (HP:0100653) | 3.70456840 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.70456840 |
| 20 | * Gingivitis (HP:0000230) | 3.69621514 |
| 21 | * Chronic obstructive pulmonary disease (HP:0006510) | 3.60916756 |
| 22 | * Obstructive lung disease (HP:0006536) | 3.60916756 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.54925907 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.54925907 |
| 25 | Vasculitis (HP:0002633) | 3.47983069 |
| 26 | Recurrent viral infections (HP:0004429) | 3.44056739 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.43587986 |
| 28 | Increased IgM level (HP:0003496) | 3.43354715 |
| 29 | Pustule (HP:0200039) | 3.37962690 |
| 30 | Axonal loss (HP:0003447) | 3.32856024 |
| 31 | Increased IgE level (HP:0003212) | 3.28196261 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.25299995 |
| 33 | Basal ganglia calcification (HP:0002135) | 3.21425380 |
| 34 | Disinhibition (HP:0000734) | 3.09403411 |
| 35 | Dysostosis multiplex (HP:0000943) | 3.04937024 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02175049 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02175049 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02175049 |
| 39 | Petechiae (HP:0000967) | 2.99460883 |
| 40 | Periodontitis (HP:0000704) | 2.94598129 |
| 41 | * Cellulitis (HP:0100658) | 2.88740628 |
| 42 | * Meningitis (HP:0001287) | 2.87603196 |
| 43 | Encephalitis (HP:0002383) | 2.87495595 |
| 44 | Chronic otitis media (HP:0000389) | 2.83074502 |
| 45 | Increased serum ferritin (HP:0003281) | 2.82712707 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.79080627 |
| 47 | Amyloidosis (HP:0011034) | 2.71398153 |
| 48 | * Urticaria (HP:0001025) | 2.67988278 |
| 49 | Hypergammaglobulinemia (HP:0010702) | 2.61113942 |
| 50 | IgM deficiency (HP:0002850) | 2.57573227 |
| 51 | Leukocytosis (HP:0001974) | 2.57440476 |
| 52 | Agnosia (HP:0010524) | 2.55230399 |
| 53 | Poor head control (HP:0002421) | 2.53687279 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.50317647 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.50086680 |
| 56 | Hemoptysis (HP:0002105) | 2.49929146 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.49767030 |
| 58 | Glomerulonephritis (HP:0000099) | 2.47810996 |
| 59 | Chest pain (HP:0100749) | 2.45637159 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43959133 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.43959133 |
| 62 | Epistaxis (HP:0000421) | 2.40374031 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.39856412 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.38961884 |
| 65 | Arterial thrombosis (HP:0004420) | 2.36975466 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.35976561 |
| 67 | * Recurrent pneumonia (HP:0006532) | 2.35296414 |
| 68 | Granulocytopenia (HP:0001913) | 2.34060641 |
| 69 | Nasal polyposis (HP:0100582) | 2.33085634 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32944251 |
| 71 | Prostate neoplasm (HP:0100787) | 2.30755804 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.29367243 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.28464810 |
| 74 | Abnormality of T cells (HP:0002843) | 2.27964086 |
| 75 | * Osteomyelitis (HP:0002754) | 2.27689781 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.27403935 |
| 77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27125548 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.26563615 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22986019 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22986019 |
| 81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22986019 |
| 82 | Lymphopenia (HP:0001888) | 2.22227383 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.22175913 |
| 84 | T lymphocytopenia (HP:0005403) | 2.20596313 |
| 85 | Tetraparesis (HP:0002273) | 2.18625890 |
| 86 | Purpura (HP:0000979) | 2.18325716 |
| 87 | Malnutrition (HP:0004395) | 2.18170069 |
| 88 | Episodic fever (HP:0001954) | 2.16925739 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 2.16721396 |
| 90 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.16680193 |
| 91 | Restrictive lung disease (HP:0002091) | 2.16216623 |
| 92 | Gingival bleeding (HP:0000225) | 2.15626244 |
| 93 | Hypochromic anemia (HP:0001931) | 2.13939491 |
| 94 | Hypertensive crisis (HP:0100735) | 2.13215391 |
| 95 | Loss of speech (HP:0002371) | 2.12543612 |
| 96 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.12407692 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 2.12087715 |
| 98 | Thick nail (HP:0001805) | 2.12054772 |
| 99 | Inflammation of the large intestine (HP:0002037) | 2.11759717 |
| 100 | Pulmonary embolism (HP:0002204) | 2.11350514 |
| 101 | Autoimmune hemolytic anemia (HP:0001890) | 2.11182233 |
| 102 | Thrombocytosis (HP:0001894) | 2.10416259 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.10326170 |
| 104 | Cheilitis (HP:0100825) | 2.09250618 |
| 105 | * Sepsis (HP:0100806) | 2.07194491 |
| 106 | Colitis (HP:0002583) | 2.06410314 |
| 107 | Joint hemorrhage (HP:0005261) | 2.06383239 |
| 108 | Nausea (HP:0002018) | 2.03795090 |
| 109 | Abnormality of the pleura (HP:0002103) | 2.03788505 |
| 110 | Eosinophilia (HP:0001880) | 2.03695307 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 2.03645689 |
| 112 | Upper motor neuron abnormality (HP:0002127) | 2.03437620 |
| 113 | Recurrent sinusitis (HP:0011108) | 2.03039637 |
| 114 | * Skin ulcer (HP:0200042) | 2.02725270 |
| 115 | Polygenic inheritance (HP:0010982) | 2.00835743 |
| 116 | Arthralgia (HP:0002829) | 1.98017988 |
| 117 | Bone pain (HP:0002653) | 1.97416335 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 1.97413457 |
| 119 | Emphysema (HP:0002097) | 1.97068684 |
| 120 | Pathologic fracture (HP:0002756) | 1.96624292 |
| 121 | Anorexia (HP:0002039) | 1.96387716 |
| 122 | Myocardial infarction (HP:0001658) | 1.96137998 |
| 123 | Combined immunodeficiency (HP:0005387) | 1.96026429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.30614053 |
| 2 | MAP3K14 | 4.11916169 |
| 3 | RIPK4 | 3.81678888 |
| 4 | TBK1 | 3.43977528 |
| 5 | MAP4K1 | 3.40682166 |
| 6 | IRAK4 | 3.25841818 |
| 7 | PBK | 3.00161003 |
| 8 | TYK2 | 2.77839248 |
| 9 | IKBKE | 2.63804504 |
| 10 | TXK | 2.58550424 |
| 11 | PRPF4B | 2.53617717 |
| 12 | IRAK3 | 2.50378659 |
| 13 | ERN1 | 2.36983998 |
| 14 | IKBKB | 2.34946884 |
| 15 | NME2 | 2.25904132 |
| 16 | JAK3 | 2.24848708 |
| 17 | KIT | 2.21190521 |
| 18 | PIM2 | 2.04947233 |
| 19 | ZAP70 | 1.88031488 |
| 20 | TAOK1 | 1.80327736 |
| 21 | TAOK2 | 1.76239208 |
| 22 | TNK2 | 1.72053710 |
| 23 | JAK1 | 1.65924387 |
| 24 | SYK | 1.65264426 |
| 25 | BTK | 1.58808898 |
| 26 | CSK | 1.53835921 |
| 27 | TEC | 1.42932287 |
| 28 | LYN | 1.33242596 |
| 29 | HCK | 1.33188471 |
| 30 | CHUK | 1.32796374 |
| 31 | SMG1 | 1.32330470 |
| 32 | NEK9 | 1.32111770 |
| 33 | CSF1R | 1.30074419 |
| 34 | STK10 | 1.29899718 |
| 35 | PIM1 | 1.27073063 |
| 36 | MST4 | 1.26800151 |
| 37 | MAP3K13 | 1.26591196 |
| 38 | ABL2 | 1.25836250 |
| 39 | RPS6KA4 | 1.23808304 |
| 40 | LCK | 1.21044304 |
| 41 | MAP3K1 | 1.20112436 |
| 42 | TGFBR2 | 1.15992732 |
| 43 | SIK1 | 1.14307573 |
| 44 | KDR | 1.13213390 |
| 45 | CLK1 | 1.09867411 |
| 46 | LRRK2 | 1.07441396 |
| 47 | STK4 | 0.97254045 |
| 48 | BMX | 0.96781706 |
| 49 | MAP3K12 | 0.94428754 |
| 50 | MST1R | 0.92469068 |
| 51 | JAK2 | 0.91107083 |
| 52 | MAP2K3 | 0.91009580 |
| 53 | MARK3 | 0.90835932 |
| 54 | EPHB1 | 0.89577255 |
| 55 | MATK | 0.87746854 |
| 56 | BMPR2 | 0.86737144 |
| 57 | TRPM7 | 0.86242376 |
| 58 | CDC42BPA | 0.85090210 |
| 59 | TESK1 | 0.84352171 |
| 60 | ITK | 0.84111037 |
| 61 | FES | 0.83116990 |
| 62 | MAP3K11 | 0.82640875 |
| 63 | PDPK1 | 0.79696719 |
| 64 | TAOK3 | 0.79573977 |
| 65 | FGR | 0.79540040 |
| 66 | GRK6 | 0.77823947 |
| 67 | PRKD2 | 0.77238586 |
| 68 | PDK1 | 0.76107612 |
| 69 | FGFR4 | 0.72411585 |
| 70 | MARK2 | 0.71272598 |
| 71 | SIK2 | 0.68587809 |
| 72 | EIF2AK2 | 0.67894180 |
| 73 | * PRKCD | 0.65197927 |
| 74 | MAPK12 | 0.64644710 |
| 75 | FGFR3 | 0.62705776 |
| 76 | ABL1 | 0.61807238 |
| 77 | TESK2 | 0.60191104 |
| 78 | ERBB3 | 0.58049030 |
| 79 | YES1 | 0.56089641 |
| 80 | SIK3 | 0.54745265 |
| 81 | ARAF | 0.54691611 |
| 82 | GRK7 | 0.54503288 |
| 83 | HIPK2 | 0.53777365 |
| 84 | EGFR | 0.52782236 |
| 85 | TRIB3 | 0.52516974 |
| 86 | MAP2K2 | 0.52093765 |
| 87 | KSR2 | 0.52027823 |
| 88 | CDK4 | 0.51916395 |
| 89 | ICK | 0.50309903 |
| 90 | MAPK11 | 0.49801315 |
| 91 | PRKCQ | 0.49062824 |
| 92 | MAP2K6 | 0.47877637 |
| 93 | MAP3K8 | 0.47090289 |
| 94 | RPS6KA6 | 0.45257291 |
| 95 | CAMKK2 | 0.42783580 |
| 96 | MAP3K10 | 0.42560714 |
| 97 | PAK4 | 0.42161998 |
| 98 | BCKDK | 0.41618219 |
| 99 | MAPKAPK2 | 0.39581300 |
| 100 | MAPK4 | 0.38475567 |
| 101 | CAMKK1 | 0.38195364 |
| 102 | NLK | 0.37716472 |
| 103 | MAP3K5 | 0.37189346 |
| 104 | PTK6 | 0.36854757 |
| 105 | MAPK7 | 0.36846925 |
| 106 | DYRK1B | 0.36402522 |
| 107 | MAP3K3 | 0.36289430 |
| 108 | RPS6KA2 | 0.36188532 |
| 109 | IRAK1 | 0.35918004 |
| 110 | DAPK3 | 0.35344110 |
| 111 | EIF2AK3 | 0.35185844 |
| 112 | PKN2 | 0.35037991 |
| 113 | PRKG2 | 0.33865572 |
| 114 | RPS6KC1 | 0.31914113 |
| 115 | RPS6KL1 | 0.31914113 |
| 116 | ADRBK2 | 0.31450893 |
| 117 | TTN | 0.30266770 |
| 118 | RIPK1 | 0.29445421 |
| 119 | EPHA3 | 0.29016126 |
| 120 | EIF2AK1 | 0.28814309 |
| 121 | MOS | 0.28436306 |
| 122 | FYN | 0.28420789 |
| 123 | SCYL2 | 0.28084180 |
| 124 | ACVR1B | 0.27774337 |
| 125 | FLT3 | 0.26280242 |
| 126 | BMPR1B | 0.24361506 |
| 127 | MYLK | 0.23991654 |
| 128 | IGF1R | 0.22272410 |
| 129 | IRAK2 | 0.22210348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.25345807 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.23044994 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80811760 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.65927038 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64715496 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.63502091 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.60563070 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.58703291 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.40248009 |
| 10 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27976909 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.27661131 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.24153537 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20886966 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19617254 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19353126 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16988713 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.16621480 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 2.11443111 |
| 19 | Measles_Homo sapiens_hsa05162 | 2.07269353 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06511900 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93998069 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87167144 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85350445 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.80002534 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78211253 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70607402 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65636017 |
| 28 | * Phagosome_Homo sapiens_hsa04145 | 1.64867108 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.64410512 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63894442 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.62482505 |
| 32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.59197713 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51778869 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48041084 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47682143 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45200035 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.42039629 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.40928803 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34942435 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33872274 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27955448 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25169994 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23423192 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20648807 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.01056427 |
| 46 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98477804 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93498027 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92783621 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91770074 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90459453 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89365999 |
| 52 | Proteasome_Homo sapiens_hsa03050 | 0.84058579 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.82428386 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82426272 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79382276 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76086728 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75578202 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.74621585 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73116074 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71644549 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66101492 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65708031 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.64813182 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62531212 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61535282 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.59824316 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59062737 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56732000 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56323966 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53420467 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53138636 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50879378 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49507484 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48888877 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45773212 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45081453 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40611772 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40041550 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39880681 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38212422 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37098006 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36770473 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.36691715 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.35346594 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34771501 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34158197 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33752645 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33501119 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31538707 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31104571 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30974041 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30678723 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28917158 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28381253 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28249674 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28232064 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28193138 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27621049 |
| 99 | Ribosome_Homo sapiens_hsa03010 | 0.26290914 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25906263 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.25415903 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24303377 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23406687 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22982892 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.22821430 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20952309 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20677784 |
| 108 | Base excision repair_Homo sapiens_hsa03410 | 0.20211762 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.17634305 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17082992 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.16769820 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15809050 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14887659 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13277184 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.12954770 |

